SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 153 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q3 2016. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $2,000 | -98.6% | 21,083 | -73.6% | 0.00% | – |
| Q2 2018 | $139,000 | +63.5% | 80,000 | +73.0% | 0.00% | – |
| Q1 2018 | $85,000 | -24.1% | 46,232 | -8.1% | 0.00% | – |
| Q4 2017 | $112,000 | -81.6% | 50,287 | -76.0% | 0.00% | -100.0% |
| Q3 2017 | $608,000 | +371.3% | 209,676 | +623.2% | 0.00% | – |
| Q2 2017 | $129,000 | -39.4% | 28,991 | -25.0% | 0.00% | -100.0% |
| Q3 2016 | $213,000 | -36.4% | 38,660 | -38.8% | 0.00% | -50.0% |
| Q3 2015 | $335,000 | -47.3% | 63,128 | -17.7% | 0.00% | -50.0% |
| Q2 2015 | $636,000 | +1225.0% | 76,676 | +544.3% | 0.00% | +300.0% |
| Q2 2014 | $48,000 | -58.3% | 11,900 | -45.2% | 0.00% | 0.0% |
| Q1 2014 | $115,000 | – | 21,708 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 7,590,000 | $28,842,000 | 8.26% |
| Asymmetry Capital Management, L.P. | 298,190 | $1,133,000 | 2.08% |
| ARMISTICE CAPITAL, LLC | 1,330,000 | $5,054,000 | 1.92% |
| Belmont Global Advisors, Inc. | 385,000 | $1,463,000 | 1.40% |
| Paulson & Co. | 27,756,668 | $105,475,000 | 1.07% |
| Trellus Management Company, LLC | 162,900 | $619,000 | 1.01% |
| DAFNA Capital Management LLC | 319,563 | $1,214,000 | 0.96% |
| PURA VIDA INVESTMENTS, LLC | 350,000 | $1,330,000 | 0.56% |
| WALL STREET ASSOCIATES | 269,300 | $1,023,000 | 0.41% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,603,334 | $6,093,000 | 0.34% |